We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBLG icon
3801
FibroBiologics
FBLG
$7.39M
-1,168
Closed -$21K
ANRO icon
3802
Alto Neuroscience
ANRO
$1.13B
-27,127
Closed -$58.6K
GUTS icon
3803
Fractyl Health
GUTS
$111M
-28,769
Closed -$34.2K
STI icon
3804
Solidion Technology
STI
$65.5M
-1,050
Closed -$6.34K
KYTX icon
3805
Kyverna Therapeutics
KYTX
$488M
-31,614
Closed -$61K
MGX icon
3806
Metagenomi Therapeutics
MGX
$46.1M
-15,399
Closed -$20.9K
TELO icon
3807
Telomir Pharmaceuticals
TELO
$75.7M
-11,732
Closed -$37.9K
SMXT icon
3808
Solarmax Technology
SMXT
$21.3M
-20,768
Closed -$24.9K
QTTB icon
3809
Q32 Bio
QTTB
$459M
-11,156
Closed -$18.4K
GCTS
3810
GCT Semiconductor Holding
GCTS
$200M
-11,862
Closed -$19.4K
BOLD
3811
Boundless Bio
BOLD
$63M
-12,231
Closed -$18.5K
CTNM
3812
Contineum Therapeutics
CTNM
$560M
-7,573
Closed -$52.9K
SKYE icon
3813
Skye Bioscience
SKYE
$19.3M
-14,423
Closed -$22.9K
LOGC
3814
DELISTED
ContextLogic
LOGC
-1,713
Closed -$12K
ARTV
3815
Artiva Biotherapeutics
ARTV
$569M
-14,493
Closed -$43.5K
CLYM
3816
Climb Bio
CLYM
$824M
-24,782
Closed -$30.2K
FMTO
3817
DELISTED
Femto Technologies Inc. Common Stock
FMTO
0
-$7
QVCGB
3818
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
-43
Closed -$14.3K
QVCGA
3819
DELISTED
QVC Group Inc Series A
QVCGA
-1,822
Closed -$18.3K
LGF.B
3820
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-201,190
Closed -$1.59M
LGF.A
3821
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-95,704
Closed -$847K
EVBN
3822
DELISTED
Evans Bancorp Inc
EVBN
-937
Closed -$36.5K
BERY
3823
DELISTED
Berry Global Group, Inc.
BERY
-329,895
Closed -$23M
BECN
3824
DELISTED
Beacon Roofing Supply, Inc.
BECN
-100,191
Closed -$12.4M
MKFG
3825
DELISTED
Markforged Holding Corporation
MKFG
-513
Closed -$2.4K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.